July 2020

Their Majesties the Kings of Spain present INMUNOTEK with the National Innovation Award in the Small and Medium-Sized Entities (SME) category. The act presided over by the Kings took place at the Valencia Science Museum. It was attended by the Minister of Science and Innovation, Pedro Duque, local authorities. jury and guests. The National Innovation Award is the highest award given by the Government of Spain to recognize those entities that make innovation their main business growth strategy.
More info

June 2020

INMUNOTEK obtains the certificate as innovative entity in the private and independent blockchain network of the Spanish Science and Technology Parks (BLOCKPCT) promoted by the Association of Science and Technology Parks of Spain (APTE).
More info

March 2020

INMUNOTEK has implemented action measures to minimize the impact that the COVID-19 crisis is having due to the confinement situation established in Spain with the aim of guaranteeing the supply of its products to patients.
More info

March 2020

The MV130 project presented by INMUNOTEK has been selected by ITTN (International Technology Transfer Network) among more than 300 international projects for the first Roadshow sponsored by CAST (China Association for Science and Technology) in the fight against COVID-19. MV130 induces trained immunity and confers resistance to viral infections by activating innate immunity in a stable way through metabolic and epigenetic changes on innate immune cells.
More info

December 2019

Financial Times features INMUNOTEK as an example of a Spanish company with strong growth along the years even in unfavorable situations. According to the economic newspaper, the strength of these companies is based on their commitment to innovation and competitiveness. This allows to focus its productive activity towards foreign markets, have a sustained growth and create employment.
More info